Nabi Biopharmaceuticals Announces Creation of Pharmaceuticals Business Unit Full Text
Nabi Biopharmaceuticals, 07/23/2007

1 Abbott to present positive phase 2 results from multiple interferon-free studies of combination regimens for the treatment of hepatitis c Abbott, April 5, 2012

2 AstraZeneca launches DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) tablets for high blood pressure in U.S. Full Text AstraZeneca, April 13, 2012    Free full text

3 Bayer HealthCare aims to improve diabetes management across borders Full Text BayNews International, April 13, 2012    Free full text

4 Ruxolitinib (Jakafi): A twice-daily oral kinase inhibitor indicated for the treatment of myelofibrosis Full Text Formulary , April 4, 2012    Free full text

5 Watson's generic vancocin HCL capsules receive FDA approval Full Text Watson Pharmaceuticals, April 11, 2012    Free full text

6 Label change of liraglutide demonstrates superiority compared to sitagliptin Full Text Drug Topics, April 17, 2012    Free full text

7 Fake avastin circulating in U.S. Full Text U.S. Pharmacist, April 9, 2012    Free full text

8 FDA approves once-monthly treatment for anemic adults on dialysis Full Text Drug Topics, April 5, 2012    Free full text

9 Seven years-over seven million patients served Full Text PhRMA, April 6, 2012    Free full text

10 Ucb and amgen initiate sclerostin antibody phase 3 program in patients with postmenopausal osteoporosis Full Text Amgen, April 6, 2012    Free full text

11 Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis Clinical Cancer Research, April 3, 2012    Clinical Article

12 Biomarin to host first quarter 2012 financial results conference call and webcast on thursday, april at 5:00 p.m. et Full Text BioMarin, April 6, 2012    Free full text

13 Off-label use of drugs and medical devices: a review of policy implications Clinical Pharmacology & Therapeutics, April 13, 2012

14 FDA advisory committee recommends approval of mirabegron- investigational overactive bladder treatment from astellas Full Text Astellas, April 6, 2012    Free full text

15 Blood-pressure drug might curb PTSD-related nightmares Full Text Drug Topics, April 13, 2012    Free full text

16 Update on the treatment and prevention of community-acquired pneumonia in children Full Text U.S. Pharmacist, April 6, 2012    Free full text

17 Abbott receives approval for next-generation xience prime drug eluting stent in japan Abbott, April 10, 2012

18 Selumetinib controlled recurrent low-grade serous ovarian cancer Full Text Array BioPharma, April 3, 2012    Free full text

19 FDA approves Votrient for treatment of patients with certain types of advanced soft tissue sarcoma Full Text GlaxoSmithKline, April 27, 2012    Free full text

20 Brilinta (ticagrelor) added to american college of chest physicians recommendations on antithrombotic therapy and prevention of thrombosis Full Text AstraZeneca, February 22, 2012    Free full text